In this presentation, we welcome Beyond Air, Nasdaq ticker symbol XAIR. And with us today is their CEO and Chairman, Steve Lisi.

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd.).

This Company Webcast was recorded during the Lytham Partners Spring 2024 Investor Conference.